- Home
- CIB vs ICLR Comparison
CIB vs ICLR Comparison
Compare CIB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIB | ICLR |
|---|---|---|
| Founded | 1945 | 1990 |
| Country | Colombia | Ireland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 15.1B |
| IPO Year | 1995 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CIB | ICLR |
|---|---|---|
| Price | $75.15 | $185.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $56.25 | ★ $201.46 |
| AVG Volume (30 Days) | 340.7K | ★ 944.0K |
| Earning Date | 02-19-2026 | 02-18-2026 |
| Dividend Yield | ★ 5.36% | N/A |
| EPS Growth | ★ 22.14 | N/A |
| EPS | 1.96 | ★ 7.47 |
| Revenue | $6,289,868,892.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $33.27 | N/A |
| Revenue Next Year | $7.26 | $0.39 |
| P/E Ratio | ★ $10.34 | $24.43 |
| Revenue Growth | ★ 15.25 | N/A |
| 52 Week Low | $31.78 | $125.10 |
| 52 Week High | $75.75 | $211.00 |
Technical Indicators
Market Signals| Indicator | CIB | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 83.50 | 51.01 |
| Support Level | $66.41 | $179.54 |
| Resistance Level | $68.60 | $185.99 |
| Average True Range (ATR) | 1.77 | 6.84 |
| MACD | 0.83 | -1.03 |
| Stochastic Oscillator | 94.55 | 41.24 |
Price Performance
Historical ComparisonAbout CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.